Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Novartis
BerGenBio ASA
OHSU Knight Cancer Institute
Sumitomo Pharma America, Inc.
Case Comprehensive Cancer Center